Mode
Text Size
Log in / Sign up
N/A N=24 Randomized Single-blind

Clinical Evaluation Of A New Two-Component Self-Etch Universal Adhesive

Composite Restorations · Tooth Lesions

Enrolled (actual)
24
Serious AEs
0.0%
Results posted
Jul 2015
Primary outcome: Primary: Retention — 100; 100; 100; 97 percentage of restorations

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Adhesive: OptiBond XTR; Composite: Herculite Ultra (Procedure); Adhesive: OptiBond FL; Composite: Herculite Ultra (Procedure)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of North Carolina, Chapel Hill
Primary completion
Mar 2014

Outcome Measures

OutcomeResultp-value
PRIMARY
Retention
100; 100; 100; 97
SECONDARY
Color Match
89; 76
SECONDARY
Cavosurface Margin Discoloration
89; 92
SECONDARY
Secondary Caries
100; 100
SECONDARY
Anatomic Form
97; 92
SECONDARY
Marginal Adaptation and/or Integrity
97; 89
SECONDARY
Post Operative Sensitivity
100; 100

Summary

This randomized clinical trial evaluates the clinical performance of a new two-component self-etch universal adhesive, OptiBond XTR, when applied in non-carious Class V cervical lesions without macromechanical retention (retentive grooves or bevels). The control material is OptiBond FL, a "traditional" etch/prime/bond adhesive with documented clinical performance. Eighty non-carious Class V cervical lesions are divided into two groups to be treated with either OptiBond XTR or OptiBond FL. Both adhesives are applied strictly according to the manufacturer's directions. Herculite Ultra, a nano-hybrid resin-based composite, is used as the restorative material with both adhesives. The restorations will be evaluated at insertion (baseline), 6 months, and 18 months. An optional three-year recall evaluation is also proposed. The investigators hypothesize that both adhesives will have comparable performance.

Eligibility Criteria

Inclusion Criteria

  • Subjects needing restoration of NCCLs (these include some cases where the patient has hypersensitivity and a restoration is indicated)
  • Subjects with age range 18-80 years old
  • Teeth with normal occlusion relationships

Exclusion Criteria

  • Subjects with fewer than 20 teeth
  • Subjects with poor oral hygiene and/or uncontrolled periodontal disease
  • Teeth with NCCLs with mechanical undercuts
  • Subjects with known allergies to HEMA or resin-based materials. The materials to be used are HEMA and/or resin-based materials.
  • Subjects with medical conditions that contraindicate dental treatment.
  • Subjects with xerostomia. Xerostomia is a condition where there is a decrease salivary flow (dry mouth). Decrease salivary flow is a known factor that affects the long-term prognosis of dental restorations, and would be a confounder.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01464996). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search